Impact of antithrombotic therapy on colonoscopy outcomes in FIT-positive patients: implications for polyp detection, diverticulosis and normal findings
Demographic confounding, rather than antithrombotic therapy per se, explains the crude associations in colonoscopy outcomes. The matched analysis demonstrates that antithrombotics do not independently affect polyp detection, diverticulosis prevalence or adenoma detection when age and sex are controlled for. These findings support the continued use of antithrombotics during CRC screening, shifting clinical interpretation from medication-based to demographic-based risk stratification.
Authors
- Fadi Abu Baker (ORCID: https://orcid.org/0000-0001-5428-7180)
- Rawi Hazzan (ORCID: https://orcid.org/0000-0001-7731-118X)
- Tarek Saadi
- Naim Abu‐Freha (ORCID: https://orcid.org/0000-0002-4844-3308)
- Mifleh Tatour
Institutions
- Bar-Ilan University (IL)
- Technion – Israel Institute of Technology (IL)
- Emek Medical Center (IL)
- Assuta Medical Center (IL)
- Soroka Medical Center (IL)
- Rambam Health Care Campus (IL)
- Hillel Yaffe Medical Center (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1136/bmjgast-2025-001922
- Primary Topic
- Colorectal Cancer Screening and Detection
- Type
- article
- Field-Weighted Citation Impact
- 0.00